Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
Zijian Fang(NHS Blood and Transplant), Simón Méndez‐Ferrer(University of Cambridge)
Cited by 9
Related Papers
Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging
|Cell stem cell|2019|305
A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise
|Cell stem cell|2022|55
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms
|Nature Cancer|2023|32